Ritter Pharmaceuticals, Inc.

CLOSED

加利福尼亚州洛杉矶县, California, United Statesritterpharma.comPublic11–50 employeesEstablished: 2004-01-01

Part of Qualigen Therapeutics

Clinical Trials

0 active

Approvals

Total approvals

Agencies

Regulatory bodies

Founded

2004

Overview

Trial Phase Distribution

Phase

Trials

Phase 2

50.0%

Phase 1

25.0%

Phase 3

25.0%

Trial Status Distribution

Completed

100.0%

Clinical Trials

Trials sponsored by this organization (4)

Evaluation of the Efficacy, Durability, Safety, and Tolerability of RP-G28 in Patients With Lactose Intolerance

Phase 3

Completed

interventional

Jun 2018557 participants

Effect of a Standard Meal on the Pharmacokinetic Profile of RP-G28 in Healthy Adult Male and Female Subjects

Phase 1

Completed

interventional

Mar 201814 participants

Efficacy, Safety, and Tolerability Study of RP-G28 in Subjects With Lactose Intolerance

Phase 2

Completed

interventional

Feb 2016377 participants

Effectiveness, Safety and Tolerability Study of RP-G28 for Symptoms Associated With Lactose Intolerance

Phase 2

Completed

interventional

Apr 201161 participants

Approvals

No approval data available

News

No news articles found

Back to Organizations